Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
World
Adam Eckert

What's Going On With Novavax Stock Today?

Novavax Inc (NASDAQ:NVAX) shares are trading lower Tuesday. The stock fell to new 52-week lows early in the session, but has since recovered.

Novavax on Tuesday announced that its partner, Takeda, received manufacturing and marketing approval from the Japan Ministry of Health, Labour and Welfare for its Nuvaxovid Intramuscular Injection for primary and booster immunization in individuals aged 18 and older. Nuvaxovid is Novavax' novel recombinant protein-based COVID-19 vaccine.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.